吉林尿滴白吉林男性常规体检项目,吉林男性生殖器痒是怎么回事,吉林哪个医院做早泄比较保险,吉林男科医院较好,吉林做包皮切除哪家做的专业,吉林龟头炎治疗到哪家医院好,吉林包皮过长治疗方法

CANBERRA, May 26 (Xinhua) -- Australian Health Minister Nicola Roxon on Thursday night said she will not be frightened off by the tobacco industry's attempt to lobby Malaysia to oppose the Australian government's proposal for plain packaging of cigarettes.According to ABC News, big tobacco companies have appointed a former United States ambassador to the World Trade Organization ( WTO), Peter Allgeier, to help them fight the Australian federal government's plain packaging plan, which is due to come into effect this year.An email sent to a Malaysian official and obtained by ABC News showed that Allgeier had a meeting with Malaysia's trade minister before, and he has been lobbying a Malaysian administrator to put pressure on Australia over plain packaging.Allgeier's email also stated that "members of the U.S. congress also have written to the Australian Government outlining concerns about the implications of plain packaging for the integrity of Australia's trade commitments."However, Roxon, who said she has not been approached by Malaysia on the issue, said Allgeier's appointment demonstrated just how far big tobacco is prepared to take its fight."But we won't be frightened off because big tobacco is hiring lobbyists or looking at ways to influence the action we're taking, " she told ABC television on Thursday night.The tobacco industry has already spent millions fighting plain packaging, and last year gave 5.2 million U.S. dollars to the Alliance of Australian Retailers (AAR) to fund an advertising campaign against the plan.If the cigarettes law is enforced, Australia will become the first country in the world to ban logos and brand names from cigarette packaging. Health warnings and the kind of graphic pictures will make up the majority of the packaging, while the rest of the packets will be plain olive green.

JOHANNESBURG, March 23 (Xinhua) -- Cervical cancer ranks as the second most frequent cancer among women in South Africa.Recent information from a World Health Organization (WHO) and ICO Information Center on Human Papilloma virus (HPV) and Cervical Cancer 2010 report shows that 16.84 million South African women aged 15 years and older are at risk of developing cervical cancer.Current estimates indicate that every year 5,743 women are diagnosed with cervical cancer and more than 3,000 die from the disease.About 21 percent of women in the general South African population are estimated to harbor cervical HPV infection at any given time, and 62.8 percent of invasive cervical cancers are attributed to HPV subtypes 16 or 18."Concern is growing as there appears to be an increasing epidemic of papillomavirus-induced disease involving not only the cervix but elsewhere in the female genital tract and anogenital region," said Professor Martin Hale, head of the Department of Anatomical Pathology at the University of the Witwatersrand (Wits) in Johannesburg and the National Health Laboratory Service.The South African population and people from Africa in general have high incidences of the HPV subtypes 16 or 18 according to Professor Hale. He is not entirely sure why but is of the opinion that the infection rate can be lowered."The common theory is that HPV is transmitted through sexual intercourse. If treated like a sexual disease and the necessary precautions are taken during sex the infection rate can be lowered, " Hale told Xinhua in an interview on Wednesday.HPV is also exacerbated as a result of the HIV pandemic and cause a rapid progression of premalignant dysplasia to invasive cancer in HIV positive patients.Hale believes the limited access to information and resources make it easy for the condition to thrive.However, according to Hale, a debate is still raging on how, to whom and whether the vaccine should be administered.Black women are at higher risk of contracting HPV and subsequent cervical cancer. Other risk factors that increase susceptibility include age of first intercourse, the number of children per woman, and a weakened immune system, to name a few."To avoid getting cervical cancer get the vaccine against HPV 16 and 18 infection before starting to be sexually active, have protected sex and go for regular screenings," he told Xinhua.

LOS ANGELES, April 29 (Xinhua) -- Clinical and teaching microbiology laboratories are linked with a nationwide salmonella outbreak in the United States that has killed one person and sickened dozens of others, health officials confirmed on Friday.Since August, about 73 people in 35 states have been sickened by salmonella bacteria, and some of those cases involve a strain of Salmonella typhimurium sold commercially to laboratories, officials from the Centers for Disease Control and Prevention (CDC) said in remarks published by msnbc.com.Illnesses have been tied to laboratories from Alaska to New York, with most reporting one or two cases. Five cases have been reported in Washington state and four in Minnesota.The first illness occurred late August and the most recent cases were reported March 8, according to the CDC.The patients include employees and students of the laboratories, as well as children in the homes of people who work or study at the labs.Patients ranged in age from less than one to 91, with a median age of 24, the CDC said.Cases that developed after March 19 may not yet be included in the total because of the lag time in assessing and reporting illness, said the report.CDC officials warned that bacteria used in the labs can be transmitted through contaminated lab coats, pens, notebooks, car keys and other items brought into the labs.The CDC is working with local and state health departments, the American Society for Microbiology and the Association of Public Health Laboratories to track the outbreak, the report said.Salmonella infections typically result in diarrhea, fever and abdominal cramps. They can be dangerous in very young children or people with compromised immune systems.

WASHINGTON, March 25 (Xinhua) -- Researchers at the University of Colorado (CU) and the Harvard University have found that people living at higher altitudes have a lower chance of dying from ischemic heart disease and tend to live longer than others, according to a study published this week in the Journal of Epidemiology and Community Health.They spent four years analyzing death certificates from every county in the United States. They examined cause-of-death, socio- economic factors and other issues in their research.They found that of the top 20 counties with the highest life expectancy, eleven for men and five for women were located in Colorado and Utah. And each county was at a mean elevation of 5, 967 feet above sea level. The men lived between 75.8 and 78.2 years, while women ranged from 80.5 to 82.5 years.Compared to those living near sea-level, the men lived 1.2 to 3. 6 years longer and women 0.5 to 2.5 years more."If living in a lower oxygen environment such as in our Colorado mountains helps reduce the risk of dying from heart disease it could help us develop new clinical treatments for those conditions," said Benjamin Honigman, professor of Emergency Medicine at the CU School of Medicine. "Lower oxygen levels turn on certain genes and we think those genes may change the way heart muscles function. They may also produce new blood vessels that create new highways for blood flow into the heart."Another explanation, he said, could be that increased solar radiation at altitude helps the body better synthesize vitamin D which has also been shown to have beneficial effects on the heart and some kinds of cancer.Despite these numbers, the study showed that when socio- economic factors, solar radiation, smoking and pulmonary disease were taken into account, the net effect of altitude on overall life expectancy was negligible.Still, Honigman said, altitude seems to offer protection against heart disease deaths and may also play a role in cancer development.Colorado, the highest state in the nation, is also the leanest state, the fittest state, has the fewest deaths from heart disease and a lower incidence of colon and lung cancer compared to others.